1 |
Kren, L, Muckova K, Lzicarova E, Sova M, Vybihal V, Svoboda T, Fadrus P, Smrcka M, Slaby O, Lakomy R, Vanhara P, Krenova Z, Michalek J. Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: a role in innate immunity. J Neuroimmunol. 2010;220: 131-135. DOI: 10.1016/j.jneuroim.2010.01.014
DOI
|
2 |
Elliott, RL, Jiang XP, Phillips JT, Barnett BG, Head JF. Human leukocyte antigen G expression in breast cancer: role in immunosuppression. Cancer Biother Radiopharm. 2011;26:153-157. DOI: 10.1089/cbr.2010.0924
DOI
|
3 |
Alvarez, M, Piedade J, Balseiro S, Ribas G, Regateiro F. HLA-G 3'-UTR SNP and 14-bp deletion polymorphisms in Portuguese and Guinea-Bissau populations. Int J Immunogenet. 2009;36:361-366. DOI: 10.1111/j.1744-313X.2009.00875.x
DOI
|
4 |
Ghandri, N, Gabbouj S, Farhat K, Bouaouina N, Abdelaziz H, Nouri A, Chouchane L, Hassen E. Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome. Hum Immunol. 2011;72:150-158. DOI:10.1016/j.humimm.2010.10.006
DOI
|
5 |
Castelli, EC, Mendes-Junior CT, Viana de Camargo JL, Donadi EA. HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population. Tissue Antigens. 2008;72:149-157. DOI: 10.1111/j.1399-0039.2008.01091.x
DOI
|
6 |
Jiang, Y, Chen S, Jia S, Zhu Z, Gao X, Dong D, Gao Y. Association of HLA-G 3' UTR 14-bp insertion/deletion polymorphism with hepatocellular carcinoma susceptibility in a Chinese population. DNA Cell Biol. 2011;30:1027-1032. DOI: 10.1089/dna.2011.1238
DOI
|
7 |
Tripathi, P, Abbas A, Naik S, Agrawal S. Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens. 2004;64:706-710. DOI: 10.1111/j.1399-0039.2004.00308.x
DOI
|
8 |
Chen, XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens. 2008;72:335-341. DOI: 10.1111/j.1399-0039.2008.01107.x
DOI
|
9 |
Wu, FX, Wu LJ, Luo XY, Tang Z, Yang MH, Xie CM, Liu NT, Zhou JG, Guan JL, Yuan GH. Lack of association between HLA-G 14-bp polymorphism and systemic lupus erythematosus in a Han Chinese population. Lupus. 2009;18:1259-1266. DOI: 10.1177/0961203309345756
DOI
|
10 |
Rebmann, V, Wagner S, Grosse-Wilde H. HLA-G expression in malignant melanoma. Semin Cancer Biol. 2007;17: 422-429. DOI: 10.1016/j.semcancer.2007.06.010
DOI
|
11 |
Baricordi, OR, Stignani M, Melchiorri L, Rizzo R. HLA-G and inflammatory diseases. Inflamm Allergy Drug Targets. 2008;7:67-74.
DOI
|
12 |
Simoes, RT, Goncalves MA, Castelli EC, Junior CM, Bettini JS, Discorde ML, Duarte G, Quintana SM, Simoes AL, Moreau P, Carosella ED, Soares EG, Donadi EA. HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus. Mod Pathol. 2009; 22:1075-1082. DOI: 10.1038/modpathol.2009.67
DOI
|
13 |
Rouas-Freiss, N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA. 1997;94:11520-11525.
DOI
|
14 |
Berger, DS, Hogge WA, Barmada MM, Ferrell RE. Comprehensive analysis of HLA-G: implications for recurrent spontaneous abortion. Reprod Sci. 2010;17:331-338. DOI:10.1177/1933719109356802
DOI
|
15 |
Kano, T, Mori T, Furudono M, Ishikawa H, Watanabe H, Kikkawa E, Warita T, Onizuka M, Takahashi M, Maeda Y, Naruse T, Inoko H, Kimura A. Human leukocyte antigen may predict outcome of primary recurrent spontaneous abortion treated with paternal lymphocyte alloimmunization therapy. Am J Reprod Immunol. 2007;58:383-387. DOI: 10.1111/j.1600-0897.2007.00517.x
DOI
|
16 |
Zheng, XQ, Zhu F, Shi WW, Lin A, Yan WH. The HLA-G 14 bp insertion/deletion polymorphism is a putative susceptible factor for active human cytomegalovirus infection in children. Tissue Antigens. 2009;74:317-321. DOI: 10.1111/j.1399-0039.2009.01312.x
DOI
|
17 |
Segat, L, Catamo E, Fabris A, Padovan L, Morgutti M, Crovella S. HLA-G 3' UTR haplotypes and HIV vertical transmission. AIDS. 2009;23:1916-1918.
DOI
|
18 |
Fabris, A, Catamo E, Segat L, Morgutti M, Arraes LC, de Lima-Filho JL, Crovella S. Association between HLA-G 3'UTR 14-bp polymorphism and HIV vertical transmission in Brazilian children. AIDS. 2009;23:177-182.
DOI
|
19 |
Urosevic, M, Trojan A, Dummer R. HLA-G and its KIR ligands in cancer--another enigma yet to be solved. J Pathol. 2002;196:252-253. DOI: 10.1002/path.1057
DOI
|
20 |
Lesport, E, Baudhuin J, LeMaoult J, Sousa S, Doliger C, Carosella ED, Favier B. Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell. Hum Immunol. 2009;70:1000-1005. DOI:10.1016/j.humimm.2009.07.019
DOI
|
21 |
Cordero, EA, Veit TD, da Silva MA, Jacques SM, Silla LM, Chies JA. HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens. 2009;74:308-313.
DOI
|
22 |
Piancatelli, D, Maccarone D, Liberatore G, Parzanese I, Clemente K, Azzarone R, Pisani F, Famulari A, Papola F. HLA-G 14-bp insertion/deletion polymorphism in kidney transplant patients with metabolic complications. Transplant Proc. 2009;41:1187-1188. DOI: 10.1016/j.transproceed.2009.03.028
DOI
|
23 |
Kamishikiryo, J, Maenaka K. HLA-G molecule. Curr Pharm Des. 2009;15:3318-3324.
DOI
|
24 |
Larsen, MH, Hviid TV. Human leukocyte antigen-G polymorphism in relation to expression, function, and disease. Hum Immunol. 2009;70:1026-1034. DOI: 10.1016/j.humimm.2009.07.015
DOI
|
25 |
Rebmann, V, Regel J, Stolke D, Grosse-Wilde H. Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol. 2003;13:371-377.
DOI
|
26 |
Bezuhly, M, Howlett A, Colp P, Conrad DM, Walsh N, Rowden G, Morris SF, Langley RG. Quantitative HLA-G expression in metastasising and non-metastasising primary thin cutaneous melanomas. Dermatology. 2008;217:281-283. DOI: 10.1159/000150602
DOI
|